CRChristian Bs Rajkovic

Christian Bs Rajkovic

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christian Bs Rajkovic has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Glucagon-like peptide-1 receptor agonist use and clinical outcomes after posterior cervical spinal fusion for degenerative pathologies: A large cohort retrospective analysis

    by Christian Rajkovic, Ankita Jain, Mahnoor Shafi, Oserekpamen Omobhude, Tej Azad, Austin Carpenter, Timothy F. Witham, Merritt D. Kinon, John V. Wainwright


  • A Systematic Review of Pneumocephalus as a Complication of Spinal Procedures

    by Christian Bs Rajkovic, Ankita Jain, Elizabeth Davis, Donald BS MacElroy, Shray Bs Khanna, Steve Bs Park, John V. Wainwright, Merritt D. Kinon

    Study Design: Systematic Review Objective: To systematically review cases of pneumocephalus following spinal procedures and evaluate prognosis and effective treatment options for this pathology. Summary of Background Data: Pneumocephalus is a rare complication of spinal procedures requiring unique strategies for symptom management and treatment. Intracranial air may cause acute decompensation when intracranial pressure rises rapidly, and therefore, early identification of pneumocephalus is crucial for recovery. Methods: A systematic review was performed to interrogate PubMed/MEDLINE for clinical and radiologic presentation of cases of pneumocephalus following spinal procedures. Results: A total of 105 articles were included, with 133 cases of pneumocephalus presenting as a complication of spinal procedures. The most common procedures investigated were epidural injections (38.7%) and decompression surgeries (17.0%). Tension pneumocephalus was reported in 17 cases and conveyed no increased risk of mortality ( P =0.59), ICU admission ( P =0.76), or persistent symptoms ( P =0.71). Patients receiving surgical treatment were significantly more likely to have an ICU stay during their hospital course ( P =0.005) but had no difference in symptom improvement ( P =0.35), radiologic resolution ( P =0.34), or mortality ( P =0.62) compared with medically managed patients. Patients with additional neurological sequelae were also more likely to receive surgery ( P P =0.008), persistent imaging findings ( P =0.01), ICU care ( P P =0.04), while altered mental status was associated with significantly greater risk of symptom persistence ( P =0.04), ICU stay ( P P =0.049). The overall symptom improvement rate was 86%, and the mortality rate was 5%. Conclusions: Overall prognosis for pneumocephalus as a complication of spinal procedures is favorable. Insights concerning symptom presentation can help spine surgeons improve communication regarding expected outcomes. Level of Evidence: Level IV.

  • Infectious complications of stereotactic navigation in posterior or posterolateral thoracic and lumbar spinal fusion and posterior lumbar interbody fusion for degenerative spinal disease: an ACS-NSQIP study

    by Christian Rajkovic, Victor Koltenyuk, A. Daniel Davidar, Ariel Sacknovitz, Jovanna Tracz, Amar Gopal, Matthew Merckling, Ethan Parisier, Ankita Jain, Eris Spirollari, et al.

  • Spinal dural arteriovenous fistulas presenting as intracranial subarachnoid hemorrhage: A systematic review

    by Bridget Nolan, Christian Rajkovic, Galadu Subah, Alis J Dicpinigaitis, Eric Feldstein, Ankita Jain, Eris Spirollari, Ariel Sacknovitz, Ilya Frid, Merritt Kinon, et al.

    Background: Spinal dural arteriovenous fistulas (SDAVFs) are the most common type of spinal arteriovenous malformation. Typically, these malformations present with a wide range of nonspecific symptoms indicative of thoracolumbar myelopathy. However, patients with spinal dural arteriovenous fistulas may rarely present with subarachnoid hemorrhage. Methods: A systematic review of MEDLINE and Embase databases was performed querying for cases of spinal dural arteriovenous fistulas with subarachnoid hemorrhage. Patient characteristics and outcomes investigated included spinal level of the fistula, delay of diagnosis, Hunt and Hess grade, interventions, recurrence of the fistula, and postoperative disability. Additionally, we present a unique case in which subarachnoid hemorrhage resulted from a spinal dural arteriovenous fistula that was refractory to multiple endovascular and open surgical interventions. Results: Of 116 records identified, 45 studies were included comprising 80 patients with spinal dural arteriovenous fistula and subarachnoid hemorrhage. The most common locations of the spinal dural arteriovenous fistula were in the cervical spine (57.5%) and at the craniocervical junction (35%). Patients were treated with open surgical ligation (60.0%), endovascular embolization (22.5%), or an open surgical procedure following persistent symptoms after endovascular treatment (10.0%). Overall, the prognoses among the treated patients were favorable with only two reported (2.5%) mortalities. Rates of neurologic recovery were similar when comparing endovascular and open surgical treatment. Endovascular treatment with coil embolization of a C1–C2 spinal dural arteriovenous fistula presenting as subarachnoid hemorrhage is also described. Conclusion: Spinal dural arteriovenous fistulas, particularly in the cervical spine, could be considered as a potential etiology for subarachnoid hemorrhage patients with no obvious intracranial cause. Treatment with either open surgery or embolization appears to offer a positive prognosis for both functional and angiographic outcomes.


  • Open Access

    Synthesis and Preclinical Evaluation of a Novel Oxy133-Infused Biomimetic Bone Graft Using a Rat Model of Posterolateral Spinal Fusion

    by Ethan Cottrill, Christian J. Rajkovic, Jessica Lin, Mahnoor Shafi, Jovanna A. Tracz, Vaughn Hernandez, Farhad Parhami, Timothy F. Witham


  • Intraoperative Methadone in Spine Surgery ERAS Protocols

    by Christian Bs Rajkovic, Sima Vazquez, Zach Thomas, Eris Ba Spirollari, Bridget Bs Nolan, Cameron Marshall, Nitin Sekhri, Ammar Siddiqui, Merritt D. Kinon, John V. Wainwright

    Study Design: Systematic review. Objective: To systematically review the use of intraoperative methadone in spine surgery and examine its effects on postoperative opioid use, pain, length of stay, and operative time. Summary of Background Data: Spine surgery patients commonly have a history of chronic pain and opioid use, and as a result, they are at an increased risk of severe postoperative pain. While pure mu opioids remain the standard for acute surgical pain management, they are associated with significant short-term and long-term adverse events. Methadone presents an alternative to pure mu opioids which may improve postoperative management of pain following intraoperative use. Methods: A systematic review of MEDLINE, Embase, and Web of Science databases was conducted to review existing literature detailing operating time, postoperative pain, opioid usage, and hospital length of stay (LOS) following intraoperative methadone administration in spine surgery. Results: Following screening of 994 articles and application of inclusion criteria, 8 articles were included, 4 of which were retrospective. Conventional spine surgery intraoperative analgesic strategies used as comparators for intraoperative methadone included hydromorphone, ketamine, and sufentanil. Considering patient outcomes, included studies observed that patients treated with intraoperative methadone had statistically similar or significantly reduced pain scores, opioid usage, and LOS compared with comparator analgesics. However, one study observed that intraoperative methadone used in a multimodal analgesia regimen strategy with ketamine resulted in a shortened LOS compared with the use of intraoperative methadone alone. Differences in operating time between cases that used intraoperative methadone and cases that used comparator analgesics were not statistically significant among included studies. Conclusion: Methadone may present an alternative option for both intraoperative and postoperative analgesia in spine surgery recovery protocols and may reduce postoperative pain, opioid use, and LOS while maintaining consistent operating time and reduced side effects of pure mu opioids. Level of Evidence: Level II.


  • Management of spinal trauma in pregnant patients: A systematic review of the literature

    by Christian Bs Rajkovic, Adam Bs Kiss, Alyssa Bs Lee, Aryan Ba Malhotra, Matthew Bs Merckling, Aarti Bs Jain, Galadu Subah, Sabrina Zeller, Bardiya Zangbar, Kartik Prabhakaran, et al.

    BACKGROUND: Despite the high incidence of spine trauma globally, traumatic spinal cord injury (tSCI) during pregnancy is considered a rare medical emergency. The literature on acute management of these patients is sparse compared with that of mothers with preexisting tSCI. This systematic review aims to evaluate management strategies for tSCI during pregnancy in improving neurologic, obstetric, and neonatal outcomes. METHODS: A systematic review of PubMed/MEDLINE was performed without language restriction from inception until November 2, 2023 for patients who acquired tSCI during pregnancy. Excluded articles described postpartum trauma, trauma before pregnancy, or SCI of nontraumatic etiology such as neoplastic, vascular, hemorrhagic, or ischemic origin. Primary outcomes investigated were maternal American Spinal Injury Association (ASIA) grade, pregnancy termination, cesarean delivery, prematurity, and neonatal adverse events. RESULTS: Data from 73 patients were extracted from 43 articles from 1955 to 2023. The mothers' median age was 24 years (interquartile range, 23–30 years), and the average gestational age at the time of injury was 21.1 ± 7.7 weeks. The thoracic spine was the most common segment affected (41.1%) and had the greatest proportion of complete tSCI (46.6%). Furthermore, ASIA score improvement was observed in 17 patients with 3 patients experiencing a 2-score improvement and 1 patient experiencing a 3-score improvement. Among these patients, 86% of ASIA B and 100% of ASIA C patients showed neurologic improvement, compared to only 17% of ASIA A patients. Surgically managed patients had a lower rate of neonatal adverse events than conservatively managed patients (11% vs. 34%). CONCLUSION: Acute tSCI requires a coordinated effort between a multidisciplinary team with careful consideration. While maternal neurologic improvement was observed more often following a better ASIA grade on presentation, the presence of neonatal adverse events was less common in patients treated with surgery than in patients who were managed conservatively. LEVEL OF EVIDENCE: Systematic review/Meta-analysis; Level IV.


  • Open Access

    Synthesis and evaluation of a novel vancomycin-infused, biomimetic bone graft using a rat model of spinal implant-associated infection

    by Christian J. Rajkovic, Jovanna A. Tracz, Trevor DeMordaunt, A. Daniel Davidar, Alexander Perdomo-Pantoja, Brendan F. Judy, Kevin Yang Zhang, Vaughn N. Hernandez, Jessica Lin, Julianna L. Lazzari, et al.


  • A novel rodent model of chronic spinal implant-associated infection

    by Trevor DeMordaunt, Christian J. Rajkovic, Jovanna A. Tracz, Alexander Perdomo-Pantoja, Brendan F. Judy, Vaughn N. Hernandez, Jessica Lin, Julianna L. Lazzari, Dustin A. Dikeman, Nathan K. Archer, et al.